North America Narcolepsy Market is Anticipated to Reach US$ 2,024.8 Mn in 2027

North America narcolepsy market is anticipated to reach US$ 2,024.8 Mn in 2027 from US$ 919.6 Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.3% from 2019-2027.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis - https://www.businessmarketinsights.com/sample/TIPRE00008100/?utm_source=OpenPR&utm_medium=10356

The Business Market Insights provides you regional research analysis on "North America Narcolepsy Market" and forecast to 2027. The research report provides deep insights into the regional market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the North America Narcolepsy market during the forecast period, i.e., 2020-2027.

Narcolepsy is a disorder of chronic neurological disorder; the disorder impacts the brain's ability to control sleep and wake-up cycle. A person can get affected by the disorder in childhood, young age, or in adulthood, which from 17 years to 25 years. The most widely seen symptoms seen are excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations. The disorder is a frequent disorder among the people across the North American region and is the second leading cause of excessive daytime sleepiness. According to the National Organization for Rare Disorder, it is stated that the incidences of narcolepsy are 1 in 2,000. Similarly, as per the National Institute of Neurological Disorders and Stroke, it is estimated that across the United States, nearly 135,000 to 200,000 people are living narcolepsy.

Browse Full Report @ https://www.businessmarketinsights.com/reports/north-america-narcolepsy-market/?utm_source=OpenPR&utm_medium=10356

Major key players covered in this report:
• Teva Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals plc
• Arena Pharmaceuticals, Inc.
• Graymark Healthcare, Inc.
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Mylan N.V.
• BIOPROJET
• Shionogi & Co., Ltd.
• Ligand Pharmaceuticals, Inc

The rise in sleep disorders is impacting the working efficiency of people, and it is also affecting the performance of children in the studies. Similarly, it is affecting older people. The disorder increases the risk as the age grows, and it may stop breathing activity during sleep time. According to the studies published by Oxford Academics in April 2018, it is stated that the incidences are widely seen among women. The study also stated that the incidences were higher among the people between 21-30 years of age group. It is also expected that narcolepsy is caused by environmental exposures before the age of beginning in genetically inclined individuals.

It is expected that the incidences of sleep disorders are likely to grow in the coming years. Sleep disorders have become a great concern among the people of the North American region. Over 50 million people in the region are suffering from more than 80 different sleep disorders, and nearly 20 to 30 million are living with recurrent sleep disorders every year. Thus, rising sleeping disorders are likely to demand treatment for narcolepsy, which will eventually lead to the growth of the market in the coming future.

North America Narcolepsy - Market Segmentation
North America Narcolepsy Market - By Type
• Narcolepsy with Cataplexy
• Narcolepsy without Cataplexy
• Secondary Narcolepsy

North America Market - By Product
• Central Nervous System (CNS) Stimulants
• Sodium Oxybate
• Antidepressants

North America Market - By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods - https://www.businessmarketinsights.com/buy/single/TIPRE00008100/?utm_source=OpenPR&utm_medium=10356

The research on the North America Narcolepsy market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor's methodologies. The research also segments the North America Narcolepsy market on the basis of end user, product type, application, and demography for the forecast period 2020-2027. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the North America Narcolepsy market.

Contact US:
Business Market Insights
Phone: +442081254005
E-Mail ID: sales@businessmarketinsights.com
Web URL: https://www.businessmarketinsights.com/

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.